Worthington Enterprises (WOR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting will be held virtually on September 23, 2025, with shareholders able to vote and submit questions online.
Shareholders will vote on four key proposals: election of four directors, advisory approval of executive compensation, approval of a new equity plan for non-employee directors, and ratification of KPMG as auditor.
The company reported solid financial results for fiscal 2025, including growth in adjusted EPS and EBITDA, successful integration of an acquisition, and continued share repurchases and dividends.
Leadership transitions included the appointment of a new CEO and CFO.
Voting matters and shareholder proposals
Four directors are nominated for three-year terms expiring in 2028.
Advisory vote on executive compensation (say-on-pay) is recommended for approval.
Shareholders are asked to approve the 2025 Equity Plan for Non-Employee Directors.
Ratification of KPMG as independent auditor for fiscal 2026 is recommended.
Board of directors and corporate governance
The board consists of 12 directors, with a majority being independent.
Board committees (Audit, Compensation, Nominating and Governance, Executive) are chaired and comprised solely of independent directors.
Lead Independent Director role is established to enhance governance and board effectiveness.
The board regularly reviews governance guidelines and committee charters.
Latest events from Worthington Enterprises
- Net sales and EBITDA declined, but Consumer Products grew and capital returns remained strong.WOR
Q1 20259 Jul 2026 - Adjusted EBITDA and EPS rose on margin gains and Ragasco, despite lower sales.WOR
Q2 20258 Jul 2026 - High-margin growth, innovation, and strong cash flow drive long-term market leadership.WOR
Baird 55th Annual Global Industrial Conference1 Jul 2026 - FY26 net sales rose 20% to $1.4B, with 12% adjusted EBITDA growth and strong cash flow.WOR
Q4 202624 Jun 2026 - Q3 FY2026 net sales rose 24% to $379M, with 15% EBITDA growth and strong segment gains.WOR
Q3 20269 Apr 2026 - Q4 net sales fell 13.6% and adjusted EPS was $0.74 amid major portfolio changes and strong liquidity.WOR
Q4 20243 Feb 2026 - TTM sales reached $1.3B with 22.7% EBITDA margin, fueled by M&A and segment resilience.WOR
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Net sales up 19% to $327M, driven by Building Products and acquisitions.WOR
Q2 20269 Jan 2026 - Q3 FY2025 margins and EPS rose on strong cash flow and Ragasco-driven segment growth.WOR
Q3 202526 Dec 2025